ROSA-BJORKESON DAGMAR 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Jun 1, 2021
Insider Transaction Report
Form 4
ROSA-BJORKESON DAGMAR
Director
Transactions
- Award
Option to Purchase Common Stock
2021-05-27+17,719→ 17,719 totalExercise: $17.08Exp: 2031-05-27→ Common Stock (17,719 underlying) - Award
Common Stock
2021-05-27+10,543→ 10,543 total
Footnotes (2)
- [F1]Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. 1/3rd of the shares subject to the award shall vest on each anniversary of the Vesting Commencement Date (or, if earlier in any given year, the day immediately preceding the date of the Issuer's Annual Meeting of Stockholders in such year). The Vesting Commencement Date is April 1, 2021.
- [F2]1/3rd of the options subject to the award shall vest and become exercisable on each anniversary of the Vesting Commencement Date (or, if earlier in any given year, the day immediately preceding the date of the Issuer's Annual Meeting of Stockholders in such year). The Vesting Commencement Date is April 1, 2021.